# First American Financial Corp: overview

FAF · NYSE · CIK 1472787 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/faf.md) · [Financials](/companies/faf/financials.md) · [Filings](/companies/faf/filings.md) · [Insiders](/companies/faf/insiders.md)

Latest reported revenue: [$2.08bn](/filings/0001193125-26-429203.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 23, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-429203).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,685 d](/filings/0001193125-26-055516.md) | [1,582](/filings/0001193125-26-174195.md) | [1,841](/filings/0001193125-26-314255.md) | [1,979](/filings/0001193125-26-429203.md) | [2,050 d](/filings/0001193125-26-055516.md) | [1,838](/filings/0001193125-26-174195.md) | [2,117](/filings/0001193125-26-314255.md) | [2,085](/filings/0001193125-26-429203.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [4.3% d](/filings/0001193125-26-055516.md) | [4.7%](/filings/0001193125-26-174195.md) | [7.9%](/filings/0001193125-26-314255.md) | [9.6%](/filings/0001193125-26-429203.md) | [10.3% d](/filings/0001193125-26-055516.md) | [6.8%](/filings/0001193125-26-174195.md) | [10.3%](/filings/0001193125-26-314255.md) | [8.5%](/filings/0001193125-26-429203.md) |
| Diluted EPS | $ per share | not reported | [0.71](/filings/0001193125-26-174195.md) | [1.41](/filings/0001193125-26-314255.md) | [1.84](/filings/0001193125-26-429203.md) | not reported | [1.21](/filings/0001193125-26-174195.md) | [2.12](/filings/0001193125-26-314255.md) | [1.72](/filings/0001193125-26-429203.md) |
| Free cash flow | $m | [266 d](/filings/0001193125-26-055516.md) | [(94.5)](/filings/0001193125-26-174195.md) | [309 d](/filings/0001193125-26-314255.md) | [223 d](/filings/0001193125-26-429203.md) | [325 d](/filings/0001193125-26-055516.md) | [(32.7)](/filings/0001193125-26-174195.md) | [317 d](/filings/0001193125-26-314255.md) | [197 d](/filings/0001193125-26-429203.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [9,221](/filings/0000950170-24-017418.md) | [7,605](/filings/0000950170-25-024488.md) | [6,004](/filings/0001193125-26-055516.md) | [6,128](/filings/0001193125-26-055516.md) | [7,452](/filings/0001193125-26-055516.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [13.5%](/filings/0000950170-24-017418.md) | [3.5%](/filings/0000950170-25-024488.md) | [3.6%](/filings/0001193125-26-055516.md) | [2.1%](/filings/0001193125-26-055516.md) | [8.3%](/filings/0001193125-26-055516.md) |
| Diluted EPS | $ per share | [11.14](/filings/0000950170-24-017418.md) | [2.45](/filings/0000950170-25-024488.md) | [2.07](/filings/0001193125-26-055516.md) | [1.26](/filings/0001193125-26-055516.md) | [6.00](/filings/0001193125-26-055516.md) |
| Free cash flow | $m | [1,059](/filings/0000950170-24-017418.md) | [518](/filings/0000950170-25-024488.md) | [90.9](/filings/0001193125-26-055516.md) | [679](/filings/0001193125-26-055516.md) | [763](/filings/0001193125-26-055516.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/faf/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $643.6m | 9,382,850 |  | Added +156,988 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $628.3m | 9,160,791 |  | Added +112 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $400.8m | 5,841,231 |  | Added +92,007 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $371.1m | 5,410,437 |  | Added +194,442 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $335.9m | 4,897,760 |  | Added +261,296 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $303.3m | 4,422,387 |  | Added +31,997 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $232.5m | 3,389,352 |  | Added +123,778 |
| [ARIEL INVESTMENTS, LLC](/funds/936753.md) | 2026-06-30 | $221.5m | 3,229,706 |  | Reduced −609,296 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $135.7m | 1,977,842 |  | Added +693,425 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $128.2m | 1,868,020 |  | Added +12,880 |

## Recent filings

[All 1,010 filings](/companies/faf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 19:35 ET | [10-Q](/filings/0001193125-26-429203.md) | Quarterly report, period 2026-09-30 | 0001193125-26-429203 |
| 2026-10-21 | 20:15 ET | [8-K](/filings/0001193125-26-427848.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-427848 |
| 2026-07-23 | 20:55 ET | [10-Q](/filings/0001193125-26-314255.md) | Quarterly report, period 2026-06-30 | 0001193125-26-314255 |
| 2026-07-22 | 20:15 ET | [8-K](/filings/0001193125-26-312415.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-312415 |
| 2026-05-15 | 20:15 ET | [8-K](/filings/0001193125-26-226782.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-226782 |
| 2026-04-29 | 20:10 ET | [8-K](/filings/0001193125-26-191548.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-191548 |
| 2026-04-24 | 22:30 ET | [10-Q](/filings/0001193125-26-174195.md) | Quarterly report, period 2026-03-31 | 0001193125-26-174195 |
| 2026-04-22 | 20:15 ET | [8-K](/filings/0001193125-26-170438.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-170438 |
| 2026-03-30 | 10:45 ET | [DEF 14A](/filings/0001193125-26-130349.md) | Proxy statement, period 2026-05-12 | 0001193125-26-130349 |
| 2026-02-25 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001193125-26-071782.md) | Ownership report, active investor, amended | 0001193125-26-071782 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-055516.md), filed Feb 18, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1472787
- Tickers: FAF
- Exchange: NYSE
- SIC code: 6361 Title Insurance
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.